The effects of errors in lipid measurement and assessment

Current Cardiology Reports

Volumn 4, Issue 6, 2002, Pages 501-507

  Cooper, Gerald R ^a   Myers, Gary L ^a   Kimberly, Mary M ^a   Waymack, Parvin P ^a  

^a NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID; LIPOPROTEIN;

ARTICLE; BLOOD; BLOOD SAMPLING; BODY POSTURE; CARDIOVASCULAR DISEASE; DIAGNOSTIC ERROR; EPIDEMIOLOGY; HUMAN; INFORMATION PROCESSING; SEROLOGY; STANDARD;

BLOOD SPECIMEN COLLECTION; CARDIOVASCULAR DISEASES; DATA COLLECTION; DIAGNOSTIC ERRORS; HUMANS; LIPIDS; LIPOPROTEINS; POSTURE; REFERENCE STANDARDS; SELECTION BIAS; SEROLOGIC TESTS;

EID: 0036832183     PISSN: 15233782     EISSN: 15343170     Source Type: Journal    
DOI: 10.1007/s11886-002-0114-5     Document Type: Article

References (37)

1. Cooper GR, Myers GL, Smith SJ, Schlant RC: Blood lipid measurements. Variations and practical utility. JAMA 1992, 267:1652-1660.
2. Rifai N, Dufour DR, Cooper GR: Preanalytical variation in lipid, lipoprotein, and apolipoprotein testing. In Handbook of Lipoprotein Testing, Edited by Rifai N, Warnick GR, Dominiczak MH. Washington, DC: AACC Press; 2000:161-187.
3. Smith SJ, Cooper GR, Myers GL, Sampson EJ: Biologic variability in concentrations of serum lipids: sources of variation among results from published studies and composite predicted values. Clin Chem 1993, 39:1012-1022.
4. Markel A, Brook JG, Aviram M: Increased plasma triglycerides, cholesterol and apolipoprotein E during prolonged fasting in normal subjects. Postgrad Med J 1985, 61:395-400.
5. Wallentin L, Skoldstam L: Lipoproteins and cholesterol esterification rate in plasma during a 10-day modified fast in man. Am J Clin Nutr 1980, 33:1925-1931.
6. Hagen RD, Upton SJV, Avakian EV, Grundy S: Increases in serum lipid and lipoprotein levels with movement from the supine to standing position in adult men and women. Prev Med 1986, 15:18-27.
7. Miller M, Bachorik PS, Cloey TA: Normal variation of plasma lipoproteins postural effects on plasma concentrations of lipids, lipoproteins, and apolipoproteins. Clin Chem 1992, 38:569-574.
8. Cooper GR, Sampson EJ, Smith SJ: Preanalytical, including biologic, variation in lipid and apolipoprotein measurements. Curr Opin Lipidol, 1992, 3:365-371.
9. Cloey T, Bachorik PS, Becker D, et al.: Reevaluation of serum-plasma differences in total cholesterol concentration. JAMA 1990, 263:2788-2789.
10. Beheshti I, Wessels LM, Eckfeldt JH: EDTA-plasma vs serum differences in cholesterol, high-density-lipoprotein cholesterol, and triglyceride as measured by several methods. Clin Chem 1994, 40:2088-2092.
11. Cohn JS, McNamara JR, Cohn SD, et al.: Postprandial plasma lipoprotein changes in human subjects of different ages. J Lipid Res 1988, 29:469-479.
12. Romon M, Le Fur C, Lebel P, et al.: Circadian variation of postprandial lipemia. Am J Clin Nutr 1997, 65:934-940.
13. Gore JM, Goldberg RJ, Matsumoto AS, et al.: Validity of serum total cholesterol level obtained within 24 hours of acute myocardial infarction. Am J Cardiol 1984, 54:722-725.
14. Haffner SM, Stern MP, Hazuda HP, et al.: Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 1990, 263:2893-2898.
15. Despres J-P, Lamarche B, Mariege P, et al.: Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996, 334:952-957.
16. Friis T, Pedersen LR: Serum lipids in hyper- and hypothyroidism before and after treatment. Clin Chem Acta 1987, 162:155-163.
17. Alvarez C, Ramos A: Lipids, lipoproteins and apolipoproteins in serum during infection. Clin Chem 1986, 32:142-145.
18. Bernert JT, Akins JR, Cooper GR, et al.: Factors influencing the accuracy of the National Reference System total cholesterol reference method. Clin Chem 1991, 37:2053-2061.
19. Vanderlinde RE, Bowers GN Jr., Schaffer R, Edwards GC: The national reference system for cholesterol. Clin Lab Med 1989, 9:89-104.
20. Miller WG: Matrix effects in the measurement and standardization of lipids and lipoproteins. In Handbook of Lipoprotein Testing, edn 2. Edited by Rifai N, Warnick GR, Dominiczak MH. Washington, DC: AACC Press; 2000:695-716.
21. Myers GL, Waymack PP: Matrix effects in biological reference materials used in the standardization of cholesterol measurements. Fresenius J Anal Chem 1990, 338:538-542.
22. National Cholesterol Education Program: Report from the Laboratory Standardization Panel. Recommendations for improving cholesterol measurement. NIH publication no. 90-2964. Bethesda, MD: National Institutes of Health; 1990:1-65.
23. National Committee for Clinical Laboratory Standards: Preparation and validation of commutable frozen human serum pools as secondary reference materials for cholesterol measurement procedures. C37. ANCCLS 1999, 19:1-26.
24. National Cholesterol Education Program: A report from the Laboratory Standardization Panel: current status of blood cholesterol measurement in clinical laboratories in the United States. Clin Chem 1988, 34:193-201.
25. Myers GL, Kimberly MM, Waymack PP, et al.: A Reference Method Laboratory Network for Cholesterol: a model for standardization and improvement of clinical laboratory measurements. Clin Chem 2000, 46:1762-1772.
26. Myers GL, Cooper GR, Greenberg N, et al.: Standardization of lipid and lipoprotein measurements. In Handbook of Lipoprotein Testing, end 2. Edited by Rifai N, Warnick GR, Dominiczak MH. Washington, DC: AACC Press; 2000:717-748.
27. This chapter details the CDC's standardization activities and goals. 27. National Cholesterol Education Program: Executive summary of the Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (ATP 111). JAMA 2001, 285:2486-2496.
28. D̀Agostino RB, Grundy S, Sullivan LM, Wilson P: Validation of the Framingham Coronary Heart Disease prediction scores. Results of a multiple ethnic groups investigation. JAMA 2001, 286:180-187.
29. Caudill SP, Cooper GR, Smith SJ, Myers GL: Assessment of current National Cholesterol Education Program guidelines for total cholesterol, triglyceride, HDL-cholesterol, and LDLcholesterol measurements. Clin Chem 1998, 44:1650-1658.
30. Li R, Bensen JT, Hutchinson RG, Province MA, et al.: Family risk score of coronary heart disease (CHD) as a predictor of CHD: The Atherosclerosis Risk in Communities(ARIC) Study and the NHLBI Family Heart Study. Genet Epidemiol 2000, 18:236-250.
31. Geberhiwot T, Jones AF, Bartlett WA, et al.: Laboratory-based calculation of coronary heart disease risk. Clin Chem 2001, 47:589-591.
32. Lippi G, Arosi E, Prior M, Guidi G: Biochemical risk factors for cardiovascular disease in an aged male population: emerging vascular pathogens. Angiology 2001, 52:681-687.
33. Rifai N, Ridker PM: Proposed cardiovascular risk assessment algorithm using high-sensitivity C-reactive protein and lipid screening. Clin Chem 2001, 47:28-30.
34. Cooper GR, Myers GL, Smith SJ, Sampson EJ: Standardization of lipid, lipoprotein and apolipoprotein measurements. Clin Chem 1988, 34(8B):B95-B105.
35. Centers for Disease Control and Prevention: Cholesterol Reference Method Update. CDC manual. 1994, 1-25.
36. Cooper GR, Myers GL, Henderson LO: Establishment of reference methods for lipids, lipoproteins and apolipoproteins. Eur J Clin Chem Clin Biochem 1991, 29:269-275.
37. Bonino P, Plebani M, Ceriotti F, Rubboli F: Errors in laboratory medicine. Clin Chem 2002, 48:691-698.